Norges Bank
BNR

Norges Bank’s Burning Rock Biotech BNR Stock Holding History

Norges Bank’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-27,996
Closed -$815K – 2096
2022
Q2 		$815K Hold
27,996
– – ﹤0.01% 1983
2022
Q1 		$2.6M Buy
+27,996
New +$2.43M ﹤0.01% 1955
2021
Q4 		– Sell
-15,013
Closed -$2.68M – 2213
2021
Q3 		$2.68M Buy
+15,013
New +$3.34M ﹤0.01% 2005
2021
Q2 		– Sell
-2,000
Closed -$538K – 2215
2021
Q1 		$538K Hold
2,000
– – ﹤0.01% 2086
2020
Q4 		$462K Hold
2,000
– – ﹤0.01% 2084
2020
Q3 		$502K Hold
2,000
– – ﹤0.01% 2080
2020
Q2 		$540K Buy
+2,000
New +$548K ﹤0.01% 2045

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Norges Bank's BNR Position: Q3 2022 in Review

Norges Bank sold out of Burning Rock Biotech (BNR) in Q3 2022, closing a stake of 27,996 shares — an estimated $815K sold.

Norges Bank first reported a position in BNR in Q2 2020 and held it in 7 quarters. The position peaked at $2.68M in Q3 2021. 52 funds tracked by Wall St. Rank hold BNR as of Q3 2022.

  • Norges Bank reported no remaining Burning Rock Biotech position as of Q3 2022 after selling out during the quarter.
  • Norges Bank sold 27,996 Burning Rock Biotech shares in Q3 2022, an estimated $815K.
  • Norges Bank first reported a position in Burning Rock Biotech in Q2 2020 and held it in 7 quarters.
  • Norges Bank's Burning Rock Biotech position peaked at $2.68M in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2022.

Based on Norges Bank's 13F filing for Q3 2022, filed 14 Nov 2022.